BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37943553)

  • 1. Hepatitis C in Black Individuals in the US: A Review.
    Falade-Nwulia O; Kelly SM; Amanor-Boadu S; Nnodum BN; Lim JK; Sulkowski M
    JAMA; 2023 Dec; 330(22):2200-2208. PubMed ID: 37943553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns.
    Patrick SW; Dupont WD; McNeer E; McPheeters M; Cooper WO; Aronoff DM; Osmundson S; Stein BD
    JAMA Health Forum; 2021 Oct; 2(10):e213470. PubMed ID: 35977167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist.
    Nephew LD; Wang Y; Mohamed K; Nichols D; Rawl SM; Orman E; Desai AP; Patidar KR; Ghabril M; Chalasani N; Kasting ML
    J Viral Hepat; 2022 May; 29(5):366-374. PubMed ID: 35254695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection.
    Su F; Green PK; Berry K; Ioannou GN
    Hepatology; 2017 Feb; 65(2):426-438. PubMed ID: 27775854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Treatment Initiation Among US Medicaid Enrollees.
    Kapadia SN; Zhang H; Gonzalez CJ; Sen B; Franco R; Hutchings K; Wethington E; Talal A; Lloyd A; Dharia A; Wells M; Bao Y; Shapiro MF
    JAMA Netw Open; 2023 Aug; 6(8):e2327326. PubMed ID: 37540513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C.
    Liu L; Daftary MN; Alzahrani MS; Ohanele C; Maneno MK
    J Natl Med Assoc; 2021 Apr; 113(2):147-157. PubMed ID: 32868101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vital Signs: Hepatitis C Treatment Among Insured Adults - United States, 2019-2020.
    Thompson WW; Symum H; Sandul A; ; Gupta N; Patel P; Nelson N; Mermin J; Wester C
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1011-1017. PubMed ID: 35951484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Infection Screening Within Community Health Centers.
    Cook N; Turse EP; Garcia AS; Hardigan P; Amofah SA
    J Am Osteopath Assoc; 2016 Jan; 116(1):6-11. PubMed ID: 26745559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data.
    Mkuu RS; Shenkman EA; Muller KE; Huo T; Salloum RG; Cabrera R; Zarrinpar A; Thomas E; Szurek SM; Nelson DR
    Medicine (Baltimore); 2021 Dec; 100(50):e28316. PubMed ID: 34918711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999-2016.
    Zou B; Yeo YH; Le MH; Henry L; Chang ET; Lok AS; Cheung R; Nguyen MH
    J Infect Dis; 2020 Jan; 221(3):408-418. PubMed ID: 31560391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
    Nguyen VH; Kam L; Yeo YH; Huang DQ; Henry L; Cheung R; Nguyen MH
    JAMA Netw Open; 2022 Dec; 5(12):e2245424. PubMed ID: 36477481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study.
    Clements KM; Clark RE; Lavitas P; Kunte P; Graham CS; O'Connell E; Lenz K; Jeffrey P
    J Manag Care Spec Pharm; 2016 Jun; 22(6):714-722b. PubMed ID: 27231798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured.
    Epstein RL; Wang J; White LF; Kapadia SN; Morgan JR; Bao Y; Linas BP
    Am J Prev Med; 2022 Sep; 63(3):e87-e98. PubMed ID: 35725599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status.
    Pro G; Tompkins DA; Azari S; Zaller N
    Drug Alcohol Depend; 2021 Nov; 228():109092. PubMed ID: 34571287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.
    O'Halloran AC; Holstein R; Cummings C; Daily Kirley P; Alden NB; Yousey-Hindes K; Anderson EJ; Ryan P; Kim S; Lynfield R; McMullen C; Bennett NM; Spina N; Billing LM; Sutton M; Schaffner W; Talbot HK; Price A; Fry AM; Reed C; Garg S
    JAMA Netw Open; 2021 Aug; 4(8):e2121880. PubMed ID: 34427679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.
    Hoff E; Warden A; Taylor R; Nijhawan AE
    Public Health Rep; 2023; 138(2):248-258. PubMed ID: 35238249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance.
    Kimble MM; Javanbakht M; Chew KW; Stafylis C; He D; Ramirez S; Baik Y; Saab S; Klausner JD
    BMC Infect Dis; 2019 Jul; 19(1):626. PubMed ID: 31307403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
    Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
    Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.